WGS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
GeneDx Holdings Corp (WGS) is not a strong buy for a beginner, long-term investor at this time. While there are positive aspects such as growth in revenue and bullish analyst sentiment, the recent insider selling, declining net income, and lack of strong trading signals suggest holding off on investment until clearer positive trends emerge.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 64.749, with resistance at 70.518 and support at 58.981.
Analysts maintain bullish ratings with price targets significantly higher than the current price. The company's gross margin improved slightly to 69.65%.
Net income dropped significantly (-424.86% YoY), and EPS declined by -405.00% YoY. Insider selling has increased by 813.18% over the last month. No recent news or congress trading data to support a positive sentiment shift. Technical indicators show mixed signals, with bearish moving averages.
In Q4 2025, revenue grew by 26.50% YoY to $120.99M, but net income dropped to -$17.67M (-424.86% YoY), and EPS fell to -0.61 (-405.00% YoY). Gross margin improved slightly to 69.65%.
Analysts maintain Buy or Overweight ratings with price targets ranging from $100 to $170, despite some downward revisions. Analysts are optimistic about the company's fundamentals, growth opportunities, and competitive positioning.
